But in response to C+D questioning, the General Pharmaceutical Council (GPhC) said that it was “not aware of ChatGPT being used by pharmacists or pharmacy technicians to complete their revalidation”.
ChatGPT is an artificial intelligence chatbot developed by OpenAI and released in November 2022.
However, the GPhC did warn that if a revalidation submission contained “false or misleading information”, this could result in the “administrative removal” of a registrant.
It stressed that the revalidation process is “one of the ways that we work with pharmacy professionals to provide assurance that the trust in pharmacy professionals is well placed”.
“It is important that pharmacy professionals reflect on their own learning and practice as part of the revalidation process,” it added.
Disclaimer: The accuracy and information of news stories published on this website is accurate on the date of publishing. We endeavour to update stories if information change. You can contact us with change and update requests. Where possible, we will link to sources. Content on this website is for guidance purposes only. We cannot accept any responsibility or liability whatsoever for any action taken, or not taken. You should seek the appropriate legal advice having regard to your own particular circumstances.